Curia Appoints Gerald Auer as Chief Financial Officer

ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024. “I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia […]

ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024.

“I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia CEO Philip Macnabb. “Gerald brings extensive experience leading finance divisions with an impressive track record for success. I am confident that he will be an invaluable asset to our team and will help position us for a strong year in 2024.”

Auer most recently served as CFO at Al Dahra, a company specializing in agribusiness. Prior to his time at Al Dahra, Auer was CFO of the EMEA crop science division at Bayer, a life science company focused on health care and agriculture, and CFO of Bayer Switzerland. He spent more than 20 years at Bayer and held multiple leadership roles within its finance department, leading finance functions across the global organization in the North and Latin America region as well as Europe, the Middle East and Africa. Auer studied at the University of Marburg in Germany where he earned his master’s degree in business administration.

He currently resides in Basel, Switzerland with his family, but they plan to relocate to Raleigh, North Carolina in 2024.

“Curia is a dynamic company in the CDMO space with an inspirational mission to improve patients’ lives,” said Auer. “I look forward to collaborating with the talented team at Curia to help drive that mission for our customers and their patients.”

About Curia

Curia is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 27 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8995447

Total
0
Shares
Previous Article

Desert X AlUla Third Edition of International Art Exhibition Will Open 9 February – 23 March 2024 Under the Theme of ‘In The Presence Of Absence’, Artists Will Explore That Which Cannot be Seen

Next Article

Sultan bin Ahmed attends UOS meeting on its strategy for 2024-2030

Related Posts

Kavalan Claims ‘Best of the Best’ Single Malt in Tokyo

TWSC 2021 names Kavalan 10th Anniversary Sky Gold Wine Cask Matured the best single malt in the world TAIPEI, May 31, 2021 /PRNewswire/ — Kavalan has been named the Tokyo Whisky & Spirits Competition’s (TWSC) 2021 “Best of the Best” single malt. Kavalan took out four of the contest’s top 5 single malts, ranking 1st, […]

وزير الصناعة والثروة المعدنية: المؤتمر سيكون بمثابة المنصة الشاملة والأولى لقطاع التعدين في مناطق الشرق الأوسط وآسيا الوسطى وشمال وشرق أفريقيا

برعاية كريمة من خادم الحرمين الشريفين إطلاق مؤتمر “معادن المستقبل الدولي” في دورته الأولى يناير القادم الرياض, 31 أغسطس / آب 2021 /PRNewswire/ — برعاية كريمة من خادم الحرمين الشريفين الملك سلمان بن عبدالعزيز آل سعود، أعلنت وزارة الصناعة والثروة المعدنية اليوم عن إقامة الدورة الأولى لمؤتمر “معادن المستقبل الدولي” الذي سيعقد خلال الفترة من […]

Low/no calorie sweeteners do not increase the risk of cardiovascular diseases

ISA statement in response to new study by Debras, Chazelas et al. BRUSSELS, Belgium, Sept. 08, 2022 (GLOBE NEWSWIRE) — The International Sweeteners Association (ISA) responds to the new study by Debras, Chazelas et al.1 on low/no calorie sweeteners and cardiovascular diseases highlighting that, contrary to claims made in this study, there is no causal […]